NIH reports a blood biomarker that may predict Alzheimer's symptom timing
NIH highlighted a novel Alzheimer's biomarker that beat a leading diagnostic blood test at predicting disease progression. The update points toward earlier risk awareness, while still requiring clinical interpretation.
Medical stories need careful wording. ToolerWork should summarize the research clearly and push users toward official sources, not overpromise diagnosis or treatment.